🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨New publication alert!🚨 Our IP faculty are authors on the largest multicenter prospective study of robotic-assisted bronchoscopy to date — the TARGET trial — in CHEST. 🔗 bit.ly/3ZHCs7Z #Bronchoscopy #LungCancer #MedEd #PCCM

At #ASCO2025, NYU Grossman med student Lucas Mavromatis presented data linking GLP-1 receptor agonists to a 7% lower incidence of obesity-related cancers—compared to weight-neutral DPP-4 inhibitors. #GLP1 #ObesityResearch #CancerPrevention #NYULangone

EGFR Inhibitors Could Be Effective Treatment for NF1 Melanoma Subtype The research builds on prior knowledge that #NF1 acts as a tumor suppressor by negatively regulating RAS signaling pathways NYU Langone Health Perlmutter Cancer Center at NYU Langone Health #EGFRinhibitors #melanoma hubs.li/Q03rMMKM0

In honor of #WorldBloodDonorDay, learn how blood transfusions work from Dr. Jun Choi of Perlmutter Cancer Center at NYU Langone Health. During a blood transfusion blood donated from healthy patients is infused via an IV. It’s a routine, lifesaving treatment—used for cancer patients and many others in need.

Explaining Brain Cancer and Metastases Updates for Patients Joshua Sabari, MD Manmeet Ahluwalia, MD, MBA, FASCO Perlmutter Cancer Center at NYU Langone Health @baptisthealthSF ASCO #ASCO25 #BrainCancer hubs.li/Q03sfZKj0

Understanding the Whole Person Behind their Cancer Diagnosis Joshua Sabari, MD jackie herigodt Perlmutter Cancer Center at NYU Langone Health ASCO #ASCO25 hubs.li/Q03skkYz0

🚨 Major updates in #LungCancer treatment straight from #ASCO25! Dr. @JSabarind Dr. Eric K. Singhi, MD discuss what the latest data mean for you and your loved ones. ASCO MD Anderson Cancer Center Perlmutter Cancer Center at NYU Langone Health #ASCO25 🎥 Watch the full video here: hubs.li/Q03sj8_H0

Update on CAR T-cells in CLL with VuMedi Perlmutter Cancer Center at NYU Langone Health #CLL vumedi.com/video/overview…

Live at 3:30pm East, join Marc Siegel MD as he explores the advances in breast cancer surgery with Jill Dietz, MD, MHCM JillDietz - Director of Surgical Quality and Innovation at Perlmutter Cancer Center at NYU Langone Health NYU Langone Surgery. Stream live here: sxm.app.link/DoctorRadio

Arrived in sunny Nashville!!! #ABSBrachy25 kicks off with Resident and physics session this afternoon !! Refining our skills, sharing knowledge and teaching: #ThisisBrachytherapy

Telisotuzumab Vedotin Maintains Efficacy Across Key Subgroups in Pretreated NSCLC With c-MET Overexpression #NSCLC #oncology Joshua Sabari, MD Perlmutter Cancer Center at NYU Langone Health hubs.li/Q03sRsrs0

Researchers at NYU Langone Health + @PerlmutterCC found why some melanomas with NF1 mutations resist immunotherapy and how EGFR inhibitors, already used in other cancers, may help. Read more: bit.ly/40e4BDF

Always a pleasure to speak with Dr. John Sweetenham and the #ASCODailyNews Podcast about updates in hematologic malignancies from #ASCO25 #mmsm Perlmutter Cancer Center at NYU Langone Health Link: dailynews.ascopubs.org/do/podcast-pre…

Can ctDNA Help Guide Surgical Decision Making in Breast Cancer Joshua Sabari, MD Perlmutter Cancer Center at NYU Langone Health UCLA Health #BreastCancer curetoday.com/view/can-ctdna…

Don't miss the next WCM Englander Institute for Precision Medicine #PrecisionMedicine Seminar with Dr. Parsa Mirhaji (Parsa Mirhaji) from Perlmutter Cancer Center at NYU Langone Health New York University, "Patient Screening and Clinical Trials Matching Using #LLMs" on July 17th at noon!

Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— #breastcancer. Joshua Sabari, MD Perlmutter Cancer Center at NYU Langone Health ASCO #ASCO25 hubs.li/Q03vkbZ50

Coming up at 2pm East, join Marc Siegel MD as he interviews Dr. Naomi Ko, MD, MPH - Section Chief and Disease Management Group Leader for breast cancer medical oncology at Perlmutter Cancer Center at NYU Langone Health NYU Langone Health about the future of breast cancer treatment. Tune in here: sxm.app.link/DoctorRadio

Engineers at NYU Tandon & Perlmutter Cancer Center at NYU Langone Health have published a review on human cancer-on-chip platforms used to model the tumor microenvironment. They also explore what’s next for developing next-gen systems to advance precision cancer medicine. Read more: doi.org/10.1039/D4LC01…

Sharing some personal news - excited for this next step! NYU Langone Names Chief of Division of Hematology & Medical Oncology & Director of the Center for Blood Cancers nyulangone.org/news/nyu-lango…

Huge thanks to our incredible Clinical Trials team for showcasing 9 poster presentations at Association of American Cancer Institutes's Clinical Research Innovation (#CRI2025) annual meeting last week, highlighting innovative strategies to advance effective and efficient cancer research. 👏